Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
78 days ago
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
242 days ago
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
506 days ago
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
838 days ago
TSX Ends Modestly Lower, Drops Nearly 1.5% In Week
The Canadian market ended on a weak note on Friday, extending losses to a fifth straight session, on concerns about the outlook for economic growth, and on uncertainty about the outcome of the upcoming U.S. presidential election.
RTTNews
|
18h 24min ago
Dollar Rises Against Major Counterparts
After staying quite subdued during the Asian and European sessions, and early on in the New York session, the U.S. dollar climbed higher on Friday amid bets the Federal Reserve will be less aggressive with regard to interest rate cuts, and on speculation former President Donald Trump coming to power for a second term.
RTTNews
|
18h 50min ago
Gold Futures Settle Modestly Higher For The Session, Gain 1% In Week
Gold futures settled higher on Friday despite a slightly stronger dollar, as rising predictions of a Trump presidency as well as geopolitical tensions in the Middle East pushed up demand for the safe-haven yellow metal.
RTTNews
|
21h 8min ago
Swiss Market Ends Slightly Higher
The Switzerland market ended slightly up on Friday after a choppy session as investors largely refrained from making significant moves due to a lack of triggers.
RTTNews
|
21h 44min ago
